He was diagnosed with PTSD in 2012. After leaving the military, "I just declined further and further into darkness," he says. He tried a range of medications and different types of therapy, none of which worked. It was when he was close to giving up hope that Kfoury first heard about ibogaine: a friend put him in touch with another military veteran who planned to join a study in Mexico, where ibogaine is unregulated, to investigate the drug's potential benefits for treating traumatic brain injuries and PTSD. Kfoury signed up too.
Trials on veterans suggest ibogaine could provide a new treatment for PTSD
Why This Matters
This article highlights promising early research into ibogaine as a potential treatment for PTSD, especially for veterans who have not responded to traditional therapies. If proven effective, this could revolutionize mental health treatment options for those suffering from trauma-related conditions. The findings underscore the importance of exploring alternative therapies in addressing complex psychological disorders.
Key Takeaways
- Ibogaine shows potential as a new treatment for PTSD based on veteran trials.
- Current traditional therapies may not be effective for all PTSD sufferers.
- Further research could lead to regulatory acceptance and broader use of ibogaine in mental health treatment.
Get alerts for these topics